Loading...
Natera, Inc.
NTRA•NASDAQ
HealthcareMedical - Diagnostics & Research
$163.76
$-1.75(-1.06%)
Natera, Inc. (NTRA) Financial Performance & Statements
Review Natera, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
56.75%
↑ 56.75%
Operating Income Growth
50.19%
↑ 50.19%
Net Income Growth
56.20%
↑ 56.20%
Operating Cash Flow Growth
154.93%
↑ 154.93%
Operating Margin
-12.41%
↓ 12.41%
Gross Margin
61.81%
↑ 61.81%
Net Profit Margin
-10.36%
↓ 10.36%
ROE
-18.29%
↓ 18.29%
ROIC
-16.62%
↓ 16.62%
Natera, Inc. (NTRA) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Natera, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $476.06M | $439.76M | $413.35M | $367.74M |
| Cost of Revenue | $176.42M | $168.01M | $170.18M | $159.14M |
| Gross Profit | $299.64M | $271.75M | $243.17M | $208.60M |
| Gross Profit Ratio | $0.63 | $0.62 | $0.59 | $0.57 |
| R&D Expenses | $129.46M | $96.93M | $89.11M | $88.64M |
| SG&A Expenses | $234.92M | $214.15M | $197.97M | $194.28M |
| Operating Expenses | $364.38M | $311.08M | $287.07M | $282.92M |
| Total Costs & Expenses | $540.80M | $479.10M | $457.25M | $442.06M |
| Interest Income | $10.91M | $11.62M | $10.46M | $10.27M |
| Interest Expense | $1.29M | $3.14M | $3.13M | $3.12M |
| Depreciation & Amortization | $7.79M | $8.20M | $7.92M | $10.66M |
| EBITDA | -$46.04M | -$19.52M | -$25.53M | -$53.39M |
| EBITDA Ratio | -$0.10 | -$0.04 | -$0.06 | -$0.15 |
| Operating Income | -$64.74M | -$39.34M | -$43.90M | -$74.31M |
| Operating Income Ratio | -$0.14 | -$0.09 | -$0.11 | -$0.20 |
| Other Income/Expenses (Net) | $9.61M | $8.48M | $7.33M | $7.14M |
| Income Before Tax | -$55.13M | -$30.86M | -$36.57M | -$67.17M |
| Income Before Tax Ratio | -$0.12 | -$0.07 | -$0.09 | -$0.18 |
| Income Tax Expense | -$1.35M | $730000.00 | $892000.00 | $428000.00 |
| Net Income | -$53.77M | -$31.59M | -$37.46M | -$67.60M |
| Net Income Ratio | -$0.11 | -$0.07 | -$0.09 | -$0.18 |
| EPS | -$0.41 | -$0.26 | -$0.30 | -$0.56 |
| Diluted EPS | -$0.41 | -$0.26 | -$0.30 | -$0.56 |
| Weighted Avg Shares Outstanding | $131.41M | $123.78M | $122.85M | $120.81M |
| Weighted Avg Shares Outstanding (Diluted) | $131.41M | $123.78M | $122.85M | $120.81M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan